Besides IMF, ALK fusions have also been detected in a small subset (<2–5%) of leiomyosarcoma involving a range of different fusion partners such as KANK2 and ACTG2, two proteins highly expressed in smooth muscle, and STK32B, IGFBP5, and TNS1 [27]. This evidence concerns the gene ALK and leiomyosarcoma.